Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
38.87
-0.31 (-0.79%)
At close: Oct 30, 2026, 4:00 PM EDT
38.50
-0.37 (-0.95%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year. That makes Nektar Therapeutics the 34,004th largest employer in the world and 4,485th in the United States.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$866,492
Profits / Employee
-$2,494,079
Market Cap
1.33B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 2 | 3.28% |
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Omeros | 175 |
| Taysha Gene Therapies | 99 |
| Rapport Therapeutics | 84 |
| GH Research | 73 |
| Savara | 70 |
NKTR News
- 4 days ago - Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets - PRNewsWire
- 8 days ago - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 20 days ago - Nektar initiated with an Outperform at Leerink - TheFly
- 20 days ago - Nektar initiated with a Neutral at UBS - TheFly
- 22 days ago - 3 ‘Strong Buy’ High-Risk/High-Reward Stocks to Bank on for 100%+ Upside Potential - TipRanks
- 23 days ago - Nektar initiated with a Market Perform at Raymond James - TheFly
- 27 days ago - Nektar 60% selloff brings ‘attractive buying opportunity,’ says Citi - TheFly
- 4 weeks ago - Nektar selloff yesterday overdone, says H.C. Wainwright - TheFly